LSUHS leadership, faculty, staff, students and community supporters recently honored the continued growth of research initiatives and funding at the second annual Research Celebration event held on February 25, 2020.

Aphios Granted U.S. Patent for Oral Administration of Bryostatin-1 Nanoparticles for Treatment of Neurodegenerative Diseases, which was co-invented by LSU Health Shreveport professor, Dr. J. Steven Alexander.

JanOne Acquires Worldwide, Exclusive License for Promising Treatment of Peripheral Arterial Disease (PAD), TV1001SR, which was invented by LSU Health Shreveport professor and vice chancellor for research, Dr. Chris Kevil.

LSU Health Shreveport researchers recently presented preliminary findings at the American Heart Association’s Basic Cardiovascular Sciences 2019 Scientific Sessions that use of the illegal stimulant methamphetamine causes build-up of tough protein fibers in heart muscle, which may help explain the development of enlarged hearts and heart failure in users.

Zaki Al Yafeai, Dr. Celeste Wu, Dr. Shafiul Alam and Alexandre Do Couto E Silva were recognized as American Heart Association Fellowship recipients.

Christopher Pattillo, PhD, Associate Professor of Molecular and Cellular Physiology, has received a grant from the National Heart, Lung, and Blood Institute of the NIH for his five-year project, “Cellular Reductive State Regulates Arteriogenesis.”

A paper authored by many researchers at LSU Health Shreveport on the prevention and treatment of stroke was recently published in Circulation, a journal of the American Heart Association.

Gaganpreet Kaur and Mansoureh Barzega have been awarded Malcolm-Feist Pre-Doctoral Fellowships by the Center for Cardiovascular Diseases and Sciences.

Zaki Al-Yafeai, Physiology graduate student, was recently awarded an American Heart Association Predoctoral Fellowship Award.

Mansoureh Barzegar received the Inaugural William Halpern travel award from Microcirculatory Society which was given to the top scored applicant.